NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $319,000 | -8.9% | 3,420 | +8.7% | 0.01% | -15.4% |
| Q3 2021 | $350,000 | -85.6% | 3,145 | -86.9% | 0.01% | -83.8% |
| Q1 2021 | $2,429,000 | -41.6% | 23,918 | -42.7% | 0.08% | -50.9% |
| Q4 2020 | $4,157,000 | +12.8% | 41,774 | -18.1% | 0.16% | -8.4% |
| Q3 2020 | $3,684,000 | +50.2% | 50,994 | +3.7% | 0.18% | +48.3% |
| Q2 2020 | $2,452,000 | +71.9% | 49,168 | +3.0% | 0.12% | +50.0% |
| Q1 2020 | $1,426,000 | – | 47,743 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |